Navigation Links
Story ideas from Molecular & Cellular Proteomics
Date:10/5/2007

Articles selected from the October 2007 issue of Molecular & Cellular Proteomics (Vol. 6, No. 10):

  • Preventing neurodegenerative diseases by studying proteins in the brain
  • Improving cancer diagnosis
  • Improving liver cancer diagnosis


Preventing neurodegenerative diseases by studying proteins in the brain

Researchers report the most complete list so far of the proteins present in the cerebral cortex the outermost layer of the brain that plays a central role in memory, language, cognition, and consciousness. The cerebral cortex is also the part of the brain that contains the hallmarks of many neurodegenerative diseases, so these results could help understand how such diseases develop and maybe find ways to slow it down.

Most neurodegenerative diseases develop in specific regions of the brain. For instance, loss of neurons due to Alzheimers disease (AD) occur mostly in the cerebral cortex and hippocampus, and degeneration of neurons in Parkinsons disease largely centers on an area in the back of the brain called the brainstem at least in the early stage of the disease.

Jing Zhang and colleagues identified over 800 different proteins in a part of the cortex near the forehead called the frontal cortex. This region of the brain is involved in many neurodegenerative diseases in which intellectual function deteriorates over time, including AD, Parkinsons disease with dementia (PDD), and dementia with Lewy body (DLB) disease, and frontotemporal lobar degeneration (FTLD).

The proteins identified in this study perform various functions inside the cell, such as the transport of other proteins, the activation of neighboring proteins, and the catalysis of biochemical reactions. Among these proteins, the scientists found that at least half a dozen are known to be associated with neurodegenerative diseases, but examining
'/>"/>

Contact: Nicole Kresge
nkresge@asbmb.org
301-634-7415
American Society for Biochemistry and Molecular Biology
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Leprosy genome tells story of human migrations, French researchers report in Science
2. Can our genes tell the story of our divergence?
3. Divergent life history shapes gene expression in brains of salmon
4. Restaurant seafood prices since 1850s help plot marine harvests through history
5. Finding rewrites the evolutionary history of the origin of potatoes
6. Image of myosin-actin interaction revealed in cover story of Molecular Cell
7. Embryos tell story of Earths earliest animals
8. Underdogs in the understory: Study suggests nature favors rarer trees
9. Mouse to man: The story of chromosomes
10. Illinois pig to make history as source of first complete swine genome
11. History of human cannibalism eats away at researchers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...t,s the cost of saving a teenage life? When it com...rescription medication abuse, there,s no price tag...aware that the lock-boxes they,ve installed are no... of prescription drugs. That,s why MEDNET(TM), a n..., has formed an exclusive partnership with Axius H...
(Date:11/4/2009)...l/ -- BIO-key International, Inc. (OTC Bulletin Bo...ntification software is showcasing donor and patie...being held at the New Orleans Convention Center fr...on product demonstrations of its state-of-the-art ...5 PM on Monday, October 26, Peter Lux, manager of ...
(Date:11/4/2009)...sity of North Carolina at Chapel Hill School of Me...isco have developed and experimentally tested a te...g drugs. , The researchers developed a computati...es of all known drugs are to the naturally occurri...ase targets within the cell. In a study published ...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3BIO-key(R) International Exhibiting at AABB TXPO 2Study points to new uses, unexpected side effects of already existing drugs 2New Nominee for WHO Regional Director for Europe 57339 1New Nominee for WHO Regional Director for Europe 57339 2Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 1Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 2Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 3Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 4Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 1Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 2Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 3Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 4
...erta has helped map out the animal,s life span and...species lived, says new research conducted in part...rises to me was that the overall pattern of surviv...than the catastrophic model we were expecting," sa...e and professor in the U of A,s Department of Biol...
...eceptors in breast cancer may play a role in resis...xifen treatment, according to a study in the May 1...Pak 1 is a member of a family of proteins involved...cell movement, and cell death. Previous studies h...y lead to more invasive breast cancer. , Goran ...
...nsible for singing and mating are shrinking when e...of Alberta research--the first proof that natural ...ild animal. , "These residues have been persisti...turbing," said Dr. Andrew Iwaniuk, a post-doctoral...chology. "It has been years since it has been used...
Other Biology News:Tyrannosaur survivorship -- tough times for teens 2Pak1 expression increases tamoxifen resistance in breast cancer patients 2Bird brains shrink from exposure to contaminants 2
(Date:11/6/2009)..., Nov. 6 ,, 3Q09 C...f Qutenza(TM) E.U. Marketing Authorization to Aste...s in commercial readiness activities Expanded man... Marketing; and Director, Commercial Operations A...and Audit Committee chairman , Upcoming 200...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personali... to take place on February 22-24, 2010 in Philadel...ence we will highlight key issues in forming partn...r experiences. , Minneapo... Arrowhead’s 2010 Personalized Medicine Par...
(Date:11/5/2009)... Nov. 5 DSM Pharmaceutical Product... alliance with Galenix, Saint Jean D,Illac, France... manufacturing partner for Galenix commercial prod... collaborate on business development opportunities...based on the strength of Galenix in drug product d...
(Date:11/5/2009)... 5 Transgenomic, Inc. (O... results for the quarter ended September 30, 2009....the tables that follow. ,, Third Quarter 2009 ... or $0.01 per share for the third quarter of 2009 ... share for the third quarter of 2008. ,, Net s...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...ced today,that the company initiated its pivotal P...tucel-L) in the treatment of advanced non-small ce... in the study was treated by,Dr. Lyudmila Bazhenov...sity,of California, San Diego School of Medicine.,...80821/LATH009-a ), (Photo: http://www.newscom.co...
...nderlying Cause of Cystic,Fibrosis; Oral Drug May ...ELD, N.J., Aug. 20 New phase 2 data,published tod...l drug,PTC124 demonstrates activity in nonsense-mu...eatment with PTC124 results in statistically signi...on of patients with,nonsense-mutation CF. The stud...
...ystems,(MMS) today announced a new partnership wit... the result of a legislative initiative that,estab...h benefit for North,Dakota state employees and oth...nce Pharmaceutical Care System(TM) will provide No...aining and technology to guide and,document the de...
Other Biology Technology:NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 2NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 3NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 4PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 2PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 3PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 4PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 5North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes 2
... analytical to medium scale affinity purification ...vectors. Sufficient reagents are provided for puri... or denaturing conditions. Crude samples are incub...tains STag fusion proteins. After unbound proteins...
...ines deep experience, skills and flexibility in pr...orative team chemistry. This combination enables o...oval and beyond.,With AAIBiotech, you can cou...ou get more than that: its the power of team chemi...
Mouse Anti-Human S-100 alpha/beta chain Monoclonal Antibody, Unconjugated, Clone 8B10 from Santa Cruz Biotechnology, Inc.
Corning Proculture Spinner Flask,15L,Vertical S/Arm, No. Of S/A 4,Cent Neck 100mm from Sigma-Aldrich
Biology Products: